Article Details

Vigil Neuroscience Inc: Caution Advised Amid FDA Openness to Accelerated Approval and ...

Retrieved on: 2024-07-18 19:59:34

Tags for this article:

Click the tags to see associated articles and topics

Vigil Neuroscience Inc: Caution Advised Amid FDA Openness to Accelerated Approval and .... View article details on hiswai:

Excerpt

Analyst Jeffrey Hung of Morgan Stanley maintained a Sell rating on Vigil Neuroscience Inc (VIGL – Research Report), retaining the price ta...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo